
-
Neighbours improvise first aid for wounded in besieged Sudan city
-
Tariffs could lift Boeing and Airbus plane prices even higher
-
Analysts warn US could be handing chip market to China
-
Unbeaten Miami edge Columbus in front of big MLS crowd in Cleveland
-
Social media helps fuel growing 'sex tourism' in Japan
-
'Pandora's box': alarm bells in Indonesia over rising military role
-
Alaalatoa hails 'hustling hard' Brumbies for rare Super Rugby clean sheet
-
Trio share lead at tight LA Championship
-
Sampdoria fighting relegation disaster as old heroes ride into town
-
Recovering pope expected to delight crowds at Easter Sunday mass
-
Nuggets edge Clippers in NBA playoff overtime thriller, Knicks and Pacers win
-
Force skipper clueless about extra-time rules in pulsating Super Rugby draw
-
Nuggets edge Clippers in NBA playoff overtime thriller, Pacers thump Bucks
-
Unbeaten Miami edge Columbus in front of big crowd in Cleveland
-
Kim takes one-shot lead over Thomas, Novak at RBC Heritage
-
Another round of anti-Trump protests hits US cities
-
'So grateful' - Dodgers star Ohtani and wife welcome first child
-
PSG maintain unbeaten Ligue 1 record, Marseille back up to second
-
US, Iran report progress in nuclear talks, will meet again
-
US Supreme Court intervenes to block Trump deportations
-
Hamas armed wing says fate of US-Israeli captive unknown
-
Pacers thump Bucks to open NBA playoffs
-
Sabalenka reaches Stuttgart semis as Ostapenko extends Swiatek mastery
-
Zelensky says Ukraine will observe Putin's Easter truce but claims violations
-
'Fuming' Watkins fires Villa in bid to prove Emery wrong
-
DR Congo boat fire toll revised down to 33
-
England thrash Scotland to set up France Grand Slam showdown
-
Verstappen's Red Bull 'comes alive' to claim record pole in Jeddah
-
McTominay fires Napoli level with Inter as Conte fuels exit rumours
-
Rajasthan unleash Suryavanshi, 14, as youngest IPL player but lose thriller
-
Man City boost top five bid, Aston Villa thrash in-form Newcastle
-
Villa rout Newcastle to rekindle bid to reach Champions League
-
Dumornay gives Lyon lead over Arsenal in Women's Champions League semis
-
Trans rights supporters rally in London, Edinburgh after landmark ruling
-
'We have to wait': Barca's Flick on Lewandowski injury fear
-
Bordeaux-Begles backups edge Pau to close in on Top 14 summit
-
Trans rights supporters rally outside in London, Edinburgh after landmark ruling
-
PSG beat Le Havre to stay on course for unbeaten Ligue 1 season
-
Man City close in on Champions League with Everton late show
-
14-year-old Vaibhav Suryavanshi becomes youngest IPL player
-
Barca make stunning comeback to beat Celta Vigo in Liga thriller
-
Zverev sets up birthday bash with Shelton in Munich
-
Man City boost top five bid, Southampton snatch late leveller
-
US Supreme Court intervenes to pause Trump deportations
-
Alcaraz and Rune race into Barcelona final
-
US, Iran to hold more nuclear talks after latest round
-
Man City close in on Champions League thanks to Everton late show
-
Bayern close in on Bundesliga title with Heidenheim thumping
-
Tunisia opposition figures get jail terms in mass trial
-
Putin announces 'Easter truce' in Ukraine

PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / The Investor Summit Group (ISG), today announced that Ori Warshavsky, Chief Operating Officer - US Operations and Jonny Missulawin, Chief Financial Officer of PolyPid Ltd. (Nasdaq:PYPD), a late-stage biopharma company aiming to improve surgical outcomes will be presenting at this year's Investor Summit Virtual Conference on March 11th, 2025.
The PolyPid management team will participate in one-on-one investor meetings during this event. Investors interested in meeting with PolyPid at the conference should contact their ISG representative.
About PolyPid Ltd.
PolyPid Ltd. is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
For additional PolyPid information, please visit http://www.polypid.com and follow on Twitter and LinkedIn.
Event: Q1 Investor Summit Virtual Conference
Presentation Time: 10:00 AM ET
Location: https://www.webcaster4.com/Webcast/Page/3082/52088
Conference Overview and Structure
The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.
This quarter's event is focused on MicroCap companies who are undervalued, have a catalyst, and are undervalued.
Registration for Investors
To request free registration, please go to our website (https://investorsummitgroup.com/), and click the "Registration" button.
Sponsors:
ACCESS Newswire
PCG Advisory
QuoteMedia
AGP
MZ Group
News Compliments of ACCESS Newswire
For More Information please visit: https://investorsummitgroup.com/
Or contact [email protected]
SOURCE: PolyPid Ltd.
View the original press release on ACCESS Newswire
P.Stevenson--AMWN